Found: 9
Select item for more details and to access through your institution.
Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 377, doi. 10.1007/s10637-007-9039-6
- By:
- Publication type:
- Article
Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 3, p. 253, doi. 10.1007/s10637-006-9012-9
- By:
- Publication type:
- Article
Phase II Study of 3-Hour Infusion of Paclitaxel in Patients with Previously Untreated Stage III and IV Non-Small Cell Lung Cancer.
- Published in:
- Oncology, 1997, v. 54, n. 4, p. 298, doi. 10.1159/000227707
- By:
- Publication type:
- Article
Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 3, p. 599
- By:
- Publication type:
- Article
Ga-67 tumor scan in malignant diffuse mesothelioma--comparison with CT and pathological findings.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Ectopic accumulation ofTc-HMDP in primary lung cancer in comparison with CT findings.
- Published in:
- Annals of Nuclear Medicine, 1996, v. 10, n. 3, p. 329, doi. 10.1007/BF03164740
- By:
- Publication type:
- Article
Demonstration of primary tracheobronchial amyloidosis byTc-HMDP bone SPECT.
- Published in:
- Annals of Nuclear Medicine, 1993, v. 7, n. 4, p. 269, doi. 10.1007/BF03164709
- By:
- Publication type:
- Article
Prolonged survival of a patient with lung cancer after treatment with S-1, a new oral fluoropyrimidine anticancer drug.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Prolonged survival of a patient with lung cancer after treatment with S-1, a new oral fluoropyrimidine anticancer drug.
- Published in:
- Medical Oncology, 2007, v. 24, n. 1, p. 103, doi. 10.1007/BF02685910
- By:
- Publication type:
- Article